Guidant To Push DES Program In 2005, Says Champion Fracture Issue Solved

Guidant expects to launch its Champion everolimus drug-eluting stent in Europe in mid-2005, assuming regulators agree that the firm has resolved stress fracture problems related to the device

More from Archive

More from Medtech Insight